Qasim Khan1,2, Mohammad Ismail3, Iqbal Haider4, Inam Ul Haq1, Sidra Noor1. 1. Department of Pharmacy, University of Peshawar, Khyber Pakhtunkhwa, Pakistan. 2. Department of Pharmacy, COMSATS Institute of Information Technology, Abbottabad, Pakistan. 3. Department of Pharmacy, University of Peshawar, Khyber Pakhtunkhwa, Pakistan. ismailrph@upesh.edu.pk. 4. Department of Medicine, Khyber Teaching Hospital, Peshawar, Pakistan.
Abstract
PURPOSE: Prolonged QT interval may lead to a lethal form of arrhythmia, torsades de pointes (TdP), which is associated with cardiovascular mortality. Therefore, we aimed to identify prevalence of QT interval prolongation, compare clinical characteristics of patients with normal and prolonged QT interval, and identify predictors of QT interval prolongation. METHODS: A prospective observational study was conducted in cardiology wards of two teaching hospitals in Pakistan. Bazett's correction formula was used for the calculation of QTc interval. Prevalence of QT prolongation and pro-QTc scores were calculated. Comparative analysis was performed with respect to various clinical characteristics by applying t test and chi-square test. Odds ratios were calculated using regression analysis. RESULTS: Among 417 patients, 44.6% were found having prolonged QT interval, of which, 17.3% presented with an abnormally high QTc interval (> 500 ms). Significant difference was recorded between the groups (normal vs. prolonged) with respect to age, all prescribed medications, QT drugs, number of risk factors, QT-DDIs (QT-prolonging drug-drug interactions), gender, and diuretics use. Multivariate logistic regression analysis showed significant results for various predictors such as male gender (p = 0.03), various age categories 41-50 years (p = 0.04), 51-60 years (p = 0.01), and > 60 years (p < 0.001), and diuretics (p = 0.008). CONCLUSION: A substantial number of patients in cardiology wards presented with QT prolongation. Proper considerations are needed in order to minimize the associated risk particularly in patients with abnormally high QT prolongation, old age, polypharmacy, one or more QT-prolonging drugs, and high pro-QTc scores.
PURPOSE: Prolonged QT interval may lead to a lethal form of arrhythmia, torsades de pointes (TdP), which is associated with cardiovascular mortality. Therefore, we aimed to identify prevalence of QT interval prolongation, compare clinical characteristics of patients with normal and prolonged QT interval, and identify predictors of QT interval prolongation. METHODS: A prospective observational study was conducted in cardiology wards of two teaching hospitals in Pakistan. Bazett's correction formula was used for the calculation of QTc interval. Prevalence of QT prolongation and pro-QTc scores were calculated. Comparative analysis was performed with respect to various clinical characteristics by applying t test and chi-square test. Odds ratios were calculated using regression analysis. RESULTS: Among 417 patients, 44.6% were found having prolonged QT interval, of which, 17.3% presented with an abnormally high QTc interval (> 500 ms). Significant difference was recorded between the groups (normal vs. prolonged) with respect to age, all prescribed medications, QT drugs, number of risk factors, QT-DDIs (QT-prolonging drug-drug interactions), gender, and diuretics use. Multivariate logistic regression analysis showed significant results for various predictors such as male gender (p = 0.03), various age categories 41-50 years (p = 0.04), 51-60 years (p = 0.01), and > 60 years (p < 0.001), and diuretics (p = 0.008). CONCLUSION: A substantial number of patients in cardiology wards presented with QT prolongation. Proper considerations are needed in order to minimize the associated risk particularly in patients with abnormally high QT prolongation, old age, polypharmacy, one or more QT-prolonging drugs, and high pro-QTc scores.
Entities:
Keywords:
Cardiology; Pharmacoepidemiology; QT prolongation; QT-prolonging drugs; Torsades de pointes
Authors: David Pickham; Eric Helfenbein; Julie A Shinn; Garrett Chan; Marjorie Funk; Ann Weinacker; Jia-Ni Liu; Barbara J Drew Journal: Crit Care Med Date: 2012-02 Impact factor: 7.598
Authors: Marie L De Bruin; Pim N J Langendijk; Richard P Koopmans; Arthur A M Wilde; Hubert G M Leufkens; Arno W Hoes Journal: Br J Clin Pharmacol Date: 2006-07-21 Impact factor: 4.335
Authors: Kristina H Haugaa; J Martijn Bos; Robert F Tarrell; Bruce W Morlan; Pedro J Caraballo; Michael J Ackerman Journal: Mayo Clin Proc Date: 2013-04 Impact factor: 7.616
Authors: Bengt Danielsson; Julius Collin; Anastasia Nyman; Annica Bergendal; Natalia Borg; Maria State; Lennart Bergfeldt; Johan Fastbom Journal: BMJ Open Date: 2020-03-12 Impact factor: 2.692